Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Cardot

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Biopharmaceutics & Drug Disposition|April 1, 1993
Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteersP H Degen, J M Cardot, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|May 30, 1998
The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteersJ M Cardot, J B Lecaillon, C Czendlik, et al.
Pharmaceutical Research|March 29, 2014
In vitro- in vivo correlation's dissolution limits settingB Roudier, B M Davit, E Beyssac, et al.
International Journal of Pharmaceutics|March 31, 2016
Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanismI Tomic, A Vidis-Millward, M Mueller-Zsigmondy, et al.
Clinical Pharmacokinetics|October 1, 1987
The influence of food on the bioavailability of a slow release theophylline preparationJ J Thebault, J M Aiache, F Mazoyer, et al.
Biopharmaceutics & Drug Disposition|October 1, 1995
Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady stateJ M Cardot, P Degen, G Flesch, et al.
The AAPS Journal|April 27, 2016
Implementing the Biopharmaceutics Classification System in Drug Development: Reconciling Similarities, Differences, and Shared Challenges in the EMA and US-FDA-Recommended ApproachesJ-M Cardot, A Garcia Arieta, P Paixao, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1996
Bioequivalence assessment: a pharmaceutical industry perspectiveJ Godbillon, J M Cardot, J B Lecaillon, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
Bioinversion of ibuprofen enantiomers after administration in dogs: estimation of a novel indexR Frihmat, J M Cardot, E Beyssac, et al.
Biopharmaceutics & Drug Disposition|August 1, 1994
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteersP H Degen, G Flesch, J M Cardot, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biopharmaceutics & Drug Disposition|April 1, 1993
Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteersP H Degen, J M Cardot, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|May 30, 1998
The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteersJ M Cardot, J B Lecaillon, C Czendlik, et al.
Pharmaceutical Research|March 29, 2014
In vitro- in vivo correlation's dissolution limits settingB Roudier, B M Davit, E Beyssac, et al.
International Journal of Pharmaceutics|March 31, 2016
Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanismI Tomic, A Vidis-Millward, M Mueller-Zsigmondy, et al.
Clinical Pharmacokinetics|October 1, 1987
The influence of food on the bioavailability of a slow release theophylline preparationJ J Thebault, J M Aiache, F Mazoyer, et al.
Biopharmaceutics & Drug Disposition|October 1, 1995
Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady stateJ M Cardot, P Degen, G Flesch, et al.
The AAPS Journal|April 27, 2016
Implementing the Biopharmaceutics Classification System in Drug Development: Reconciling Similarities, Differences, and Shared Challenges in the EMA and US-FDA-Recommended ApproachesJ-M Cardot, A Garcia Arieta, P Paixao, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1996
Bioequivalence assessment: a pharmaceutical industry perspectiveJ Godbillon, J M Cardot, J B Lecaillon, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
Bioinversion of ibuprofen enantiomers after administration in dogs: estimation of a novel indexR Frihmat, J M Cardot, E Beyssac, et al.
Biopharmaceutics & Drug Disposition|August 1, 1994
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteersP H Degen, G Flesch, J M Cardot, et al.
Pageof 4